Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.77 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.52 |
| ▸ | GSK3A | P49840 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5573576 | 0.94 | TDP1 (0.66) | TDP1L3MBTL1CYP1B1GSK3B | |
| SCHEMBL8434811 | 0.87 | TDP1 (1.00) | TDP1L3MBTL1CYP1B1GSK3AGSK3B | |
| SCHEMBL31035964 | 0.87 | TDP1 (1.00) | TDP1L3MBTL1CYP1B1GSK3AGSK3B | |
| SCHEMBL5093425 | 0.87 | TDP1 (1.00) | TDP1L3MBTL1CYP1B1GSK3AGSK3B | |
| SCHEMBL9219707 | 0.87 | TDP1 (1.00) | TDP1L3MBTL1CYP1B1GSK3AGSK3B | |
| SCHEMBL29263641 | 0.87 | TDP1 (1.00) | TDP1L3MBTL1CYP1B1GSK3AGSK3B | |
| SCHEMBL2187848 | 0.87 | CASP3 (0.65) | TDP1L3MBTL1CYP1B1GSK3B | |
| SCHEMBL34464362 | 0.87 | CASP3 (0.65) | TDP1L3MBTL1CYP1B1GSK3B | |
| SCHEMBL24340266 | 0.86 | TDP1 (0.79) | TDP1L3MBTL1GSK3AGSK3BACHE | |
| SCHEMBL916601 | 0.85 | TDP1 (0.96) | TDP1L3MBTL1CYP1B1GSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7662572-B2 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-20070099249-A1 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-05-03 | — | — | US | disclosed |
| WO-2007025129-A2 | COMPOSITIONS AND LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC. (US) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099249-A1 | Compositions and liquid crystals | FABP5, FABP1, SSB | TDP1 3003/4885L3MBTL1 1377/4885CYP1B1 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.